Series A startups in Switzerland
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| UniSieve | Zürich | Series A | $9.0M | 2026-10-08 |
| xorlab | Zürich | Series A | $5.8M | 2026-09-01 |
| Adaptyv Biosystems | Lausanne | Series A | $40.0M | 2026-08-25 |
| Range | Cham | Series A | $8.3M | 2026-06-18 |
| Rivia | Zürich | Series A | $15.0M | 2026-03-18 |
| Seprify | Freiburg | Series A | $15.6M | 2026-03-10 |
| Algorized | Lausanne | Series A | $13.0M | 2026-02-10 |
| Leman Biotech | Lausanne | Series A | $28.8M | 2026-01-26 |
8 rows of the CSV in 5 of its 18 columns.
- The 262 series a startups in Switzerland have raised $2.7B in total.
- 22 of them closed their most recent round in the last 12 months, $760.7M combined.
- The largest of those rounds is Kandou AI's $225.0M Series A, dated March 2026.
- The most recent is Neurogyn Ag's $4.8M Series A on 13 October 2026.
- Venture Kick is an investor in 29 of them, more than any other fund.
- Software is the most common sector, with 118 companies (45%).
- 24% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (59% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 262| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| UniSieve | UniSieve provides molecular separation membrane solutions for cleantech applications. | Energy | Zürich | Series A | $9.0M | 2026-10-08 | $19.7M | Venture Kick, European Innovation Council, Innosuisse +1 | 11 to 50 | 2018 |
| xorlab | xorlab uses machine intelligence to stop sophisticated email attacks at first sight. | Artificial intelligence | Zürich | Series A | $5.8M | 2026-09-01 | $16.4M | Venture Kick, SICTIC, Spicehaus Partners +1 | 11 to 50 | 2015 |
| Adaptyv Biosystems | Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. | Artificial intelligence | Lausanne | Series A | $40.0M | 2026-08-25 | $50.9M | Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 | 11 to 50 | 2020 |
| Range | Range enables companies to operate across stablecoins and fiat payment systems. | Fintech | Cham | Series A | $8.3M | 2026-06-18 | $11.0M | Robot Ventures, Fenbushi Capital, BitScale Capital | 11 to 50 | 2022 |
| Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| Algorized | Algorized develops software that detects people, locates them, and senses vital signs using existing wireless sensors. | Artificial intelligence | Lausanne | Series A | $13.0M | 2026-02-10 | $17.3M | Berkeley SkyDeck Fund, SICTIC, Foundation for Innovation and Technology (FIT) | 11 to 50 | 2024 |
| Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| FoRx Therapeutics | FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. | Biotech | Basel | Series A | $50.0M | 2025-12-18 | $109.4M | EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 | 11 to 50 | 2019 |
| Cerrion | Cerrion is an AI software company that develops computer vision technology for production insights. | Artificial intelligence | Zürich | Series A | $18.0M | 2025-11-24 | $23.0M | Y Combinator, Soma Capital, Rebel Fund +2 | 11 to 50 | 2021 |
| Veezoo | Veezoo is a software company offering natural-language analytics for cloud databases. | Artificial intelligence | Zürich | Series A | $6.0M | 2025-09-22 | $6.7M | Tenity, SICTIC, Innosuisse | 1 to 10 | 2016 |
| Evulpo | Evulpo is a free learning website with instructional videos, summaries, and practice units. | Education | Zürich | Series A | $10.9M | 2025-08-18 | $21.7M | Serpentine Ventures | 101 to 250 | 2020 |
| Comphya | Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. | Biotech | Lausanne | Series A | $4.0M | 2025-07-08 | $14.2M | Venture Kick, Verve Ventures, Nest Collective Foundation | 1 to 10 | 2017 |
| Adiposs | Adiposs SA is a clinical-stage life science company developing a first-in-class imaging product for cancer patients. | Biotech | Geneva | Series A | $5.0M | 2025-06-30 | $7.4M | MassChallenge, Venture Kick, FONGIT Innovation Fund +2 | 1 to 10 | 2020 |
| Voliro | Voliro develops aerial mobile robotics technology for precision work at heights. | Hardware | Zürich | Series A | $13.5M | 2025-06-16 | $29.8M | Venture Kick, Cherry Ventures, BackBone Ventures +1 | 11 to 50 | 2019 |
| Validation Cloud | Validation Cloud provides an AI platform for Web3 finance. | Artificial intelligence | Zug | Series A | $15.0M | 2025-03-06 | $21.0M | Blockchain Founders Fund, Side Door Ventures, Cadenza Ventures +2 | 11 to 50 | 2022 |
| Rhygaze | Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. | Biotech | Basel | Series A | $86.0M | 2025-01-10 | $97.3M | Google Ventures, F-Prime, ARCH Venture Partners +2 | 11 to 50 | 2024 |
| Lyfegen | Lyfegen provides SaaS rebate management software for the healthcare industry. | Fintech | Basel | Series A | $5.7M | 2024-12-11 | MassChallenge, Innosuisse, APEX Ventures +1 | 51 to 100 | 2018 | |
| LocalStack | LocalStack is a cloud development platform for building cloud and serverless apps offline. | Software | Zürich | Series A | $25.0M | 2024-11-12 | $28.2M | CRV, Notable Capital, Heavybit | 101 to 250 | 2021 |
| Gelato | Gelato provides a cloud platform that lets builders deploy their own Ethereum rollups with one click. | Software | Zug | Series A | $11.0M | 2024-10-28 | 6th Man Ventures, Nascent | 11 to 50 | 2019 | |
| Vandria | Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders. | Health care | Lausanne | Series A | $10.1M | 2024-08-21 | Innosuisse, Dolby Family Ventures, Eurostars +1 | 1 to 10 | 2021 | |
| EthonAI | EthonAI is an AI-powered platform that detects and prevents manufacturing defects. | Artificial intelligence | Zürich | Series A | $16.6M | 2024-05-30 | General Catalyst, Index Ventures, Acequia Capital (AceCap) +2 | 11 to 50 | 2021 | |
| Backed Finance | Backed Finance develops tokenized stocks on Ethereum. | Fintech | Zug | Series A | $9.5M | 2024-04-30 | Blockchain Founders Fund, Stake Capital Group, cyber•Fund +1 | 11 to 50 | 2021 | |
| Green-Y | Green-Y is a company that reduces industrial energy costs with efficient compressed air technology. | Energy | Bern | Series A | $3.3M | 2024-04-30 | Foundation for Innovation and Technology (FIT), Schweizer Kapital Global Impact Fund | 11 to 50 | 2020 | |
| Neurosterix | Neurosterix is a biopharmaceutical firm creating allosteric modulators for neurological illnesses. | Biotech | Geneva | Series A | $65.0M | 2024-04-03 | $65.0M | Perceptive Advisors, Xontogeny, Acorn Bioventures | 11 to 50 | 2024 |
| Hive | Hive is a secure cloud storage and computing platform where users rent computing resources. | Hardware | Geneva | Series A | $13.0M | 2024-03-27 | Global Ventures, OneRagtime, SC Ventures +1 | 11 to 50 | 2021 | |
| Spirecut | Spirecut makes ultrasound-guided instruments that make minimally invasive surgery widely accessible. | Health care | Muttenz | Series A | $800K | 2024-03-26 | $2.2M | Innovate UK, MassChallenge Switzerland, Innosuisse +1 | 1 to 10 | 2020 |
| Plan-B Net Zero | Plan-B Net Zero provides renewable energy and sustainability services, including energy storage and charging infrastructure. | Energy | Zug | Series A | $9.9M | 2023-12-12 | Yamato Capital | 11 to 50 | 2022 | |
| Scailyte | Scailyte delivers precision medicine through single-cell science. | Artificial intelligence | Basel | Series A | $1.8M | 2023-12-04 | $15.6M | Venture Kick, Verve Ventures, Innosuisse +2 | 11 to 50 | 2017 |
| mybacs | mybacs is a research-driven direct-to-consumer company specializing in the human microbiome. | Commerce | Zug | Series A | $5.9M | 2023-10-19 | Global Founders Capital, Social Starts, Joyance Partners +2 | 51 to 100 | 2019 | |
| TOLREMO therapeutics | TOLREMO therapeutics develops small molecules that target drug resistance pathways in cancer therapy. | Biotech | Zürich | Series A | $37.9M | 2023-09-20 | Altos Ventures, redalpine, BioMedPartners +1 | 11 to 50 | 2017 |
Table 1. Series A startups in Switzerland: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 262.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FoRx Therapeutics | FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. | Biotech | Basel | Series A | $50.0M | 2025-12-18 | $109.4M | EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 | 11 to 50 | 2019 |
| 2 | Adaptyv Biosystems | Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. | Artificial intelligence | Lausanne | Series A | $40.0M | 2026-08-25 | $50.9M | Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 | 11 to 50 | 2020 |
| 3 | Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| 4 | Cerrion | Cerrion is an AI software company that develops computer vision technology for production insights. | Artificial intelligence | Zürich | Series A | $18.0M | 2025-11-24 | $23.0M | Y Combinator, Soma Capital, Rebel Fund +2 | 11 to 50 | 2021 |
| 5 | Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| 6 | Algorized | Algorized develops software that detects people, locates them, and senses vital signs using existing wireless sensors. | Artificial intelligence | Lausanne | Series A | $13.0M | 2026-02-10 | $17.3M | Berkeley SkyDeck Fund, SICTIC, Foundation for Innovation and Technology (FIT) | 11 to 50 | 2024 |
| 7 | UniSieve | UniSieve provides molecular separation membrane solutions for cleantech applications. | Energy | Zürich | Series A | $9.0M | 2026-10-08 | $19.7M | Venture Kick, European Innovation Council, Innosuisse +1 | 11 to 50 | 2018 |
| 8 | Range | Range enables companies to operate across stablecoins and fiat payment systems. | Fintech | Cham | Series A | $8.3M | 2026-06-18 | $11.0M | Robot Ventures, Fenbushi Capital, BitScale Capital | 11 to 50 | 2022 |
| 9 | xorlab | xorlab uses machine intelligence to stop sophisticated email attacks at first sight. | Artificial intelligence | Zürich | Series A | $5.8M | 2026-09-01 | $16.4M | Venture Kick, SICTIC, Spicehaus Partners +1 | 11 to 50 | 2015 |
Table 2. Series A startups in Switzerland: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Venture Kick | Startup incubator | Schlieren, Switzerland | 29 | 11% | 3 | UniSieve, xorlab, Adaptyv Biosystems |
| 2 | SICTIC | Angel group | Zürich, Switzerland | 11 | 4% | 2 | xorlab, Algorized |
| 3 | Verve Ventures | Venture capital firm | Zug, Switzerland | 11 | 4% | ||
| 4 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 9 | 3% | 2 | Adaptyv Biosystems, Algorized |
| 5 | Innosuisse | Government investment office | Berne, Switzerland | 7 | 3% | 2 | UniSieve, Seprify |
| 6 | Founderful | Venture capital firm | Zürich, Switzerland | 5 | 2% | 2 | UniSieve, Adaptyv Biosystems |
| 7 | VI Partners | Venture capital firm | Altendorf, Switzerland | 5 | 2% | ||
| 8 | Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | 4 | 2% | 1 | FoRx Therapeutics |
| 9 | Omega Funds | Secondary purchaser | Boston, United States | 4 | 2% | 1 | FoRx Therapeutics |
| 10 | Swisscom Ventures | Venture capital firm | Zürich, Switzerland | 4 | 2% | ||
| 11 | MassChallenge Switzerland | Startup accelerator | Renens, Switzerland | 3 | 1% | 1 | Seprify |
| 12 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 3 | 1% | 1 | FoRx Therapeutics |
| 13 | Global Founders Capital | Private equity firm | Berlin, Germany | 3 | 1% | 1 | enshift |
| 14 | Tenity | Startup accelerator | Zürich, Switzerland | 3 | 1% | ||
| 15 | MassChallenge | Startup accelerator | Boston, United States | 3 | 1% |
Table 3. Series A startups in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 118 | 45% | $1.4B |
| Health care | 89 | 34% | $1.0B |
| Biotech | 56 | 21% | $985.6M |
| Artificial intelligence | 40 | 15% | $1.1B |
| Fintech | 38 | 15% | $292.3M |
| Hardware | 30 | 11% | $876.7M |
| Commerce | 16 | 6% | |
| Energy | 10 | 4% | $551.9M |
| Cybersecurity | 10 | 4% | $46.9M |
| Education | 3 | 1% | $26.8M |
Table 4. Series A startups in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 262 | 100% | $6.0M |
Table 5. Series A startups in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Series A startups in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 9% | $13.8M |
| September 2026 | 2 | 9% | $5.8M |
| August 2026 | 2 | 9% | $240.0M |
| June 2026 | 2 | 9% | $13.6M |
| April 2026 | 2 | 9% | $35.7M |
| March 2026 | 4 | 18% | $262.5M |
| February 2026 | 2 | 9% | $13.8M |
| January 2026 | 1 | 5% | $28.8M |
| December 2025 | 1 | 5% | $50.0M |
| November 2025 | 4 | 18% | $96.8M |
Table 7. Series A startups in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 17 | 6% | $613.9M |
| 2025 | 32 | 12% | $552.2M |
| 2024 | 32 | 12% | $287.2M |
| 2023 | 19 | 7% | $207.6M |
| 2022 | 24 | 9% | $312.0M |
| 2021 | 31 | 12% | $190.9M |
Table 8. Series A startups in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 8 | 3% |
| 2020 to 2022 | 54 | 21% |
| 2015 to 2019 | 113 | 43% |
| 2010 to 2014 | 51 | 20% |
| Before 2010 | 35 | 13% |
Table 9. Series A startups in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 53 | 20% |
| 11 to 50 | 152 | 59% |
| 51 to 100 | 37 | 14% |
| 101 to 250 | 14 | 5% |
| 251 to 500 | 2 | 1% |
| 1,001 to 5,000 | 1 | 0% |
Table 10. Series A startups in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series A and its headquarters is in Switzerland. On 16 November 2026 that is 262 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 262 rows: 53 have no round amount, 0 no city and 122 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series a startups in Switzerland are on the list?
- 262, in the file dated 16 November 2026. 22 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 262 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.